As with other drugs, Remicade (infliximab) can cause side effects, such as infusion reactions. If you are not able to tolerate side effects of Remicade, talk with your doctor or pharmacist.

Remicade is J&J's biggest selling drug, with Q3 data showing sales of almost $1.8 billion, up more than 10% on the same period last year. Most of the sales are based in the US as the drug is ...

The most aggressive infliximab biosimilar discounting has been seen in the Nordic countries where Celltrion’s drug was sold at around a third of the price of the MSD originator. Tim de Gavre Tim ...

Infliximab is a chimeric monoclonal antibody ... have occurred in patients receiving certolizumab pegol, and the drug label contains a black-box warning of the risk of serious infections 6.

As Remdantry uses the same Drug Identification Number (DIN ... followed by the first and only subcutaneous (SC) formulation infliximab, ‘Remsima ® SC’, which was also approved in Canada ...